Moderna on Tuesday released preliminary data indicating its vaccine is likely to hold up against several variants of concern, including the Delta variant, which is predicted to become the dominant ...
A new preprint study suggests that Moderna’s COVID-19 vaccine may be significantly more effective against symptomatic disease from the delta variant compared to Pfizer-BioNTech’s vaccine, while the ...
Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.). Moderna said its booster candidates also ...
Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna's COVID-19 vaccines for the ...
To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver College of Medicine and a member of the U.S. Food and Drug Administration’s ...
The Centers for Disease Control and Prevention listed the COVID-19 delta variant as one of its "variants of concern" (VOCs) on June 15. According to the CDC, VOCs can be more contagious, more ...
SAN FRANCISCO (KGO) -- Bay Area doctors and health officials are concerned about the rapid spread of the COVID-19 Delta variant, warning significant outbreaks could trigger a setback for the state.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results